We are live on ! Find out more
CRDF icon

Cardiff Oncology

66 hedge funds and large institutions have $56.3M invested in Cardiff Oncology in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

66% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $1.15M

10% more funds holding

Funds holding: 6066 (+6)

5% less capital invested

Capital invested by funds: $59.2M → $56.3M (-$2.99M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.73%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
22
Reduced
13
Closed
7
Calls
$1.91M
Puts
$1.15M
Net Calls
+$761K
Net Calls Change
-$41K
Name Holding Trade Value Shares
Change
Change in
Stake
BM
1
Bridger Management
New York
$17.8M
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.04M +$298K +761 +6%
BFA
3
BlackRock Fund Advisors
California
$4.36M +$202K +516 +5%
MWVC
4
Morgens Waterfall Vintiadis & Co
New York
$4.27M
BIT
5
BlackRock Institutional Trust
California
$3.35M +$474K +1,210 +16%
First Eagle Investment Management
6
First Eagle Investment Management
New York
$2.03M +$2.05M +5,224 New
CWG
7
C WorldWide Group
Denmark
$1.77M
State Street
8
State Street
Massachusetts
$1.74M +$104K +266 +6%
Northern Trust
9
Northern Trust
Illinois
$1.66M
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$1.46M +$371K +948 +34%
DADC
11
D.A. Davidson & Co
Montana
$995K +$373K +952 +59%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$977K +$32.5K +83 +3%
TCIM
13
TIAA CREF Investment Management
New York
$890K -$192K -489 -18%
SM
14
Sabby Management
Florida
$865K -$217K -554 -20%
Goldman Sachs
15
Goldman Sachs
New York
$855K +$62.3K +159 +8%
PFS
16
Prospera Financial Services
Texas
$823K +$52.1K +133 +7%
Morgan Stanley
17
Morgan Stanley
New York
$714K +$97.9K +250 +16%
WMSA
18
Weiss Multi-Strategy Advisers
New York
$594K
BIM
19
BlackRock Investment Management
Delaware
$567K +$7.83K +20 +1%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$503K
AIG
21
American International Group
New York
$492K +$43.9K +112 +10%
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$417K +$420K +1,072 New
CC
23
Casdin Capital
New York
$378K +$381K +972 New
WFG
24
Windsor Financial Group
Minnesota
$338K
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$296K +$5.48K +14 +2%

CRDF Hedge Fund Activity: Q4 2015 in Review

66 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2015, worth a combined $56.3M — down 5% from $59.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRDF positions and 7 closed out — a net gain of 6 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $2.05M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $3.13M sold.

  • 66 institutional investors held Cardiff Oncology (CRDF) as of Q4 2015, up from 60 in Q3 2015.
  • Funds reported $56.3M of Cardiff Oncology stock for Q4 2015, down 5% quarter-over-quarter.
  • 13 funds opened new Cardiff Oncology positions in Q4 2015 and 7 closed out, a net change of +6 holders.
  • The largest Cardiff Oncology buyer in Q4 2015 was First Eagle Investment Management, an estimated $2.05M added.
  • The largest Cardiff Oncology seller in Q4 2015 was Tekla Capital Management, an estimated $3.13M sold.

Based on aggregated 13F filings for Q4 2015.